TORONTO -- DELISTING REVIEW - Chemokine Therapeutics Corp. (the "Company") - TSX is reviewing the common shares of the Company (Symbol: CTI) with respect to meeting the requirements for continued listing. The common shares of the Company are suspended from trading immediately and the Company is being reviewed on an expedited basis.
About TMX Group (TSX-X) -----------------------
TMX Group's key subsidiaries operate cash and derivative markets for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange, Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies provide trading markets, clearing facilities, data products and other services to the global financial community. TMX Group is headquartered in Toronto with offices in Montreal, Calgary and Vancouver. For more information about TMX Group, visit our website at www.tsx.com.
SOURCE: TSX Reviews and Suspensions
SOURCE: Toronto Stock Exchange
SOURCE: TSX Corporate Announcements
SOURCE: TMX GROUP INC.
Corporate Communications, TMX Group Inc., Toll Free 1-888-873-8392, firstname.lastname@example.org